Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/3a/d5/f8/3ad5f817-8a67-6cfc-f028-a21b2c25ca0e/mza_10571649192769493108.jpg/600x600bb.jpg
Talking Points
TCTMD
193 episodes
1 week ago
Mamas Mamas and Gi-byoung Nam discuss edoxaban monotherapy in patients with high-risk AF and stable CAD.
Show more...
Science
RSS
All content for Talking Points is the property of TCTMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Mamas Mamas and Gi-byoung Nam discuss edoxaban monotherapy in patients with high-risk AF and stable CAD.
Show more...
Science
https://i1.sndcdn.com/avatars-000211435609-f6to4w-original.jpg
The EPIC-CAD Trial
Talking Points
12 minutes 8 seconds
4 months ago
The EPIC-CAD Trial
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary artery disease.
Talking Points
Mamas Mamas and Gi-byoung Nam discuss edoxaban monotherapy in patients with high-risk AF and stable CAD.